Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer

Medicine & Life Sciences

• Mutagens 100%
• Somatomedins 90%
• Head and Neck Neoplasms 85%
• Recurrence 48%
• Insulin-Like Growth Factor I 28%
• Neoplasms 27%
• Insulin-Like Growth Factor Binding Protein 3 17%
• Confidence Intervals 16%
• Chromatids 8%
• Bleomycin 8%
• Chemoprevention 7%
• Proportional Hazards Models 6%
• Case-Control Studies 5%
• Research Design 5%
• Lymphocytes 4%
• Placebos 4%
• Odds Ratio 4%
• Prospective Studies 4%
• Serum 3%